SBIO
Fund Stats as of 11/17/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $30.59
Last Trade Price $30.66
NAV $30.62
NAV Change $0.17
Total Net Assets $124,011,322
Total Market Value $124,026,107
Premium/Discount(%) -0.10%
Difference ($) $-0.03
Volume 10,854
Shares Outstanding 4,050,000
Expenses as of 03/31/2017
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 91 total, as of 11/17/2017, subject to change

SecuritySymbolWeight
Bluebird Bio Inc.BLUE5.77%
Nektar TherapeuticsNKTR5.46%
Exelixis Inc.EXEL4.73%
Galapagos NVGLPG3.58%
Taro Pharmaceutical Industries Ltd.TARO3.56%
Akorn Inc.AKRX3.24%
FibroGen Inc.FGEN2.88%
Advanced Accelerator Applications SAAAAP2.77%
BeiGene Ltd.BGNE2.77%
ACADIA Pharmaceuticals Inc.ACAD2.64%
Sage Therapeutics Inc.SAGE2.49%
Ligand Pharmaceuticals Inc.LGND2.28%
GW Pharmaceuticals PLCGWPH2.28%
Agios Pharmaceuticals Inc.AGIO2.23%
Portola Pharmaceuticals Inc.PTLA2.21%
OPKO Health Inc.OPK2.14%
Spark Therapeutics Inc.ONCE2.06%
Halozyme Therapeutics Inc.HALO2.01%
Loxo Oncology Inc.LOXO1.74%
Horizon Pharma PLCHZNP1.73%
Aerie Pharmaceuticals Inc.AERI1.66%
Ironwood Pharmaceuticals Inc.IRWD1.63%
Ultragenyx Pharmaceutical Inc.RARE1.59%
Array BioPharma Inc.ARRY1.53%
Supernus Pharmaceuticals Inc.SUPN1.50%
Aimmune Therapeutics Inc.AIMT1.37%
Global Blood Therapeutics Inc.GBT1.37%
Endo International PLCENDP1.30%
Pacira Pharmaceuticals Inc.PCRX1.26%
Theravance Biopharma Inc.TBPH1.25%
Emergent BioSolutions Inc.EBS1.21%
AnaptysBio Inc.ANAB1.21%
Intercept Pharmaceuticals Inc.ICPT1.18%
Acceleron Pharma Inc.XLRN1.16%
MyoKardia Inc.MYOK1.01%
Impax Laboratories Inc.IPXL0.96%
Ascendis Pharma ASASND0.93%
DBV Technologies SADBVT0.88%
Enanta Pharmaceuticals Inc.ENTA0.72%
Biohaven Pharmaceutical Holding Co. Ltd.BHVN0.71%
Lannett Co. Inc.LCI0.69%
Acorda Therapeutics Inc.ACOR0.64%
Revance Therapeutics Inc.RVNC0.62%
Flexion Therapeutics Inc.FLXN0.58%
Adaptimmune Therapeutics PLCADAP0.57%
Five Prime Therapeutics Inc.FPRX0.57%
Epizyme Inc.EPZM0.57%
Akebia Therapeutics Inc.AKBA0.56%
MacroGenics Inc.MGNX0.55%
Aclaris Therapeutics Inc.ACRS0.53%
PTC Therapeutics Inc.PTCT0.51%
Aduro Biotech Inc.ADRO0.51%
Adamas Pharmaceuticals Inc.ADMS0.50%
G1 Therapeutics Inc.GTHX0.45%
Paratek Pharmaceuticals Inc.PRTK0.44%
Axovant Sciences Ltd.AXON0.42%
Achaogen Inc.AKAO0.39%
UroGen Pharma Ltd.URGN0.38%
Sucampo Pharmaceuticals Inc.SCMP0.38%
AMAG Pharmaceuticals Inc.AMAG0.38%
Achillion Pharmaceuticals Inc.ACHN0.36%
Concert Pharmaceuticals Inc.CNCE0.36%
Reata Pharmaceuticals Inc.RETA0.36%
Jounce Therapeutics Inc.JNCE0.36%
Atara Biotherapeutics Inc.ATRA0.35%
PDL BioPharma Inc.PDLI0.34%
Aurinia Pharmaceuticals IncAUPH0.33%
Progenics Pharmaceuticals Inc.PGNX0.30%
Depomed Inc.DEPO0.30%
Seres Therapeutics Inc.MCRB0.30%
NantKwest Inc.NK0.30%
Avadel Pharmaceuticals PLCAVDL0.29%
BioCryst Pharmaceuticals Inc.BCRX0.28%
Corbus Pharmaceuticals Holdings Inc.CRBP0.27%
Ra Pharmaceuticals Inc.RARX0.25%
Idera Pharmaceuticals Inc.IDRA0.25%
Aquinox Pharmaceuticals Inc.AQXP0.20%
Ovid therapeutics Inc.OVID0.18%
Minerva Neurosciences Inc.NERV0.17%
Forward Pharma ASFWP0.17%
Chimerix Inc.CMRX0.17%
Syndax PharmaceuticSNDX0.15%
Tocagen Inc.TOCA0.15%
Zynerba Pharmaceuticals Inc.ZYNE0.14%
Otonomy Inc.OTIC0.13%
Ocular Therapeutix Inc.OCUL0.11%
Matinas BioPharma Holdings Inc.MTNB0.08%
Versartis Inc.VSAR0.05%
Dyax Corp. - CVRDYAX-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.03%
Cash and Equivalents0.03%
Total Net Assets 100.00%
Security
Bluebird Bio Inc.
Nektar Therapeutics
Exelixis Inc.
Galapagos NV
Taro Pharmaceutical Industries Ltd.
Akorn Inc.
FibroGen Inc.
Advanced Accelerator Applications SA
BeiGene Ltd.
ACADIA Pharmaceuticals Inc.
Sage Therapeutics Inc.
Ligand Pharmaceuticals Inc.
GW Pharmaceuticals PLC
Agios Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
OPKO Health Inc.
Spark Therapeutics Inc.
Halozyme Therapeutics Inc.
Loxo Oncology Inc.
Horizon Pharma PLC
Aerie Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc.
Ultragenyx Pharmaceutical Inc.
Array BioPharma Inc.
Supernus Pharmaceuticals Inc.
Aimmune Therapeutics Inc.
Global Blood Therapeutics Inc.
Endo International PLC
Pacira Pharmaceuticals Inc.
Theravance Biopharma Inc.
Emergent BioSolutions Inc.
AnaptysBio Inc.
Intercept Pharmaceuticals Inc.
Acceleron Pharma Inc.
MyoKardia Inc.
Impax Laboratories Inc.
Ascendis Pharma AS
DBV Technologies SA
Enanta Pharmaceuticals Inc.
Biohaven Pharmaceutical Holding Co. Ltd.
Lannett Co. Inc.
Acorda Therapeutics Inc.
Revance Therapeutics Inc.
Flexion Therapeutics Inc.
Adaptimmune Therapeutics PLC
Five Prime Therapeutics Inc.
Epizyme Inc.
Akebia Therapeutics Inc.
MacroGenics Inc.
Aclaris Therapeutics Inc.
PTC Therapeutics Inc.
Aduro Biotech Inc.
Adamas Pharmaceuticals Inc.
G1 Therapeutics Inc.
Paratek Pharmaceuticals Inc.
Axovant Sciences Ltd.
Achaogen Inc.
UroGen Pharma Ltd.
Sucampo Pharmaceuticals Inc.
AMAG Pharmaceuticals Inc.
Achillion Pharmaceuticals Inc.
Concert Pharmaceuticals Inc.
Reata Pharmaceuticals Inc.
Jounce Therapeutics Inc.
Atara Biotherapeutics Inc.
PDL BioPharma Inc.
Aurinia Pharmaceuticals Inc
Progenics Pharmaceuticals Inc.
Depomed Inc.
Seres Therapeutics Inc.
NantKwest Inc.
Avadel Pharmaceuticals PLC
BioCryst Pharmaceuticals Inc.
Corbus Pharmaceuticals Holdings Inc.
Ra Pharmaceuticals Inc.
Idera Pharmaceuticals Inc.
Aquinox Pharmaceuticals Inc.
Ovid therapeutics Inc.
Minerva Neurosciences Inc.
Forward Pharma AS
Chimerix Inc.
Syndax Pharmaceutic
Tocagen Inc.
Zynerba Pharmaceuticals Inc.
Otonomy Inc.
Ocular Therapeutix Inc.
Matinas BioPharma Holdings Inc.
Versartis Inc.
Dyax Corp. - CVR
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets